Annual Report


Regeneron Pharmaceuticals is a technology leader included in Fortune’s list of the most innovative companies. As Regeneron’s technology platform produces a growing number of FDA-approved products, the company has the challenge of reaffirming its focus on meeting the needs of individual patients while continuing to tell the story of its robust drug candidate pipeline.

  • Regeneron 2013 Annual Report


Wyant Simboli emphasized Regeneron’s patient focus by featuring stories about patients whose medical conditions are being treated with the aid of Regeneron therapeutics. Full-page photographs of patients help the reader connect with each person’s story and serve as the launching point for links to videos, produced by our company, about the patients.